Gastric cancer is the second leading cause of cancer-related death in Japan. The stage of gastric cancer is dicided on depth of tumor invation, degree of lymph nodes metastases, and existence or non- existence of distant metastasis. A therapeutic strategy of gastric cancer patient is decided according to his clinical stage. Very early gastric cancer is treated by endoscopic resection, such as endoscopic mucosal resection or endoscopic submucosal dissection. On the other hand, far advanced gastric cancer with distant metastasis is treated with chemotherapy or best supportive care. Surgical resection with regional lymphadenectomy remains only curative treatment for most of gastric cancer.
Laparoscopic gastrectomy offers significant advantages on short-term outcomes compared with open surgery for patients with gastric cancer. Approximately 90 % of patients with gastric cancer, including both early and advanced cancers, have underwent radical laparoscopic gastrectomy in our hospital. The clinical pathway of laparoscopic distal gastrectomy provides discharge from the hospital post operative 10th days due to advantages on short-term outcomes of laparoscopic surgery.
Though surgical procedures in gastrointestinal cancer became less invasive by laparoscopic surgery, there remains several high invasive surgical procedures such as esophagectomy and pancreatico- duodenectomy. Further, elderly patients, especially over 80 years old, and patients who were treated with chemotherapy pre- or post-operatively have been increasing. Perioperative oral care is expected to have a pivotal role in these patients to avoid postoperative complications, including aspiration pneumonia.
Cooperation between medical and dental doctors would provide safe surgery and medication for patients with gastrointestinal cancer.
View full abstract